-A A +A
April 15, 2011

The cost of provincial pharmacare is set to rise precipitously, with spending on Ontario’s drug benefit plan for seniors projected to increase from about 1 percent of provincial income to a full 5 percent by 2061, according to a new C.D. Howe Institute report. To prepare for this rising spending on drugs as babyboomers age and workforce growth slows, authors Colin Busby and William Robson recommend partial prefunding of the Ontario Drug Benefit program as the best way to put the program on a stronger and more sustainable footing.

 

Colin Busby

Colin Busby is Director of Policy Engagement at the C.D. Howe Institute. He leads the Institute’s pension policy program as well as its Intelligence Memos.

William Robson

Bill Robson took office as President and CEO of the C.D. Howe Institute in July 2006, after serving as the Institute’s Senior Vice President since 2003 and Director of Research from 2000 to 2003. He has written more than 280 monographs, articles, chapters and books on such subjects as government budgets, pensions, healthcare financing, inflation and currency issues.